Biological markers during early treatment of tamoxifen resistant breast cancer with gefitinib ('Iressa')[Abstract]

Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Gutteridge, E., Robertson, J. F., Wakeling, A. E., Jones, Helen E. and Nicholson, Robert Ian 2004. Biological markers during early treatment of tamoxifen resistant breast cancer with gefitinib ('Iressa')[Abstract]. Breast Cancer Research and Treatment 88 (S1) , S32. 10.1007/s10549-004-3602-z

Full text not available from this repository.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Pharmacy
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology
Additional Information:	Abstract for 27th Annual The Charles A. Coltman, Jr. San Antonio Breast Cancer Symposium
Publisher:	Springer Verlag
ISSN:	0167-6806
Last Modified:	18 Oct 2022 14:18
URI:	https://orca.cardiff.ac.uk/id/eprint/17095

Actions (repository staff only)

Edit Item